search
Back to results

CogMe for the Prevention and Early Detection of Delirium (CogMe)

Primary Purpose

Delirium

Status
Recruiting
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
CogMe Personal Assistant (PA)
Sponsored by
Rambam Health Care Campus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Delirium focused on measuring Elderly, Acute hospitalization, Technology

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male and female patients aged 65 years of age and older.
  • Patients with an expected length of hospitalization of 4 days or longer.
  • Patients who are conscious and cognitively able to provide written informed consent as suggested by a score of 0 on 4AT screening.
  • Patients who have no diagnosis of delirium prior to enrollment.

Exclusion Criteria:

  • Male and female patients younger than 65 years of age.
  • Patients with an expected length of hospitalization of less than 4 days.
  • Patients with uncorrected visual or hearing impairment.
  • Patients with impaired consciousness or cognitive impairment as determined by a score of 1 or more on 4AT screening.

Sites / Locations

  • Rambam Health Care CampusRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

CogMe Personal Assistant (PA)

Arm Description

The CogMe PA is a dedicated application built by CogMe with the purpose of assessing the cognitive functions of patients and providing them with a short and stimulating interaction. The application runs on a standard tablet. The CogMe PA is designed to be easily understandable and usable also for older adults with little or no experience in mobile applications. The questions in the Q&A session are based on validated cognitive tests shown to be associated with delirium and are built to assess the subjective wellbeing and cognitive function of the patients. The repeated use of the application will allow to detect any changes or anomalies during the hospitalization period.

Outcomes

Primary Outcome Measures

The detection of delirium by the CogMe system
Time between the detection of delirium by the CogMe Data Analytics model and the first diagnosis of delirium based on the Confusion Assessment Method (CAM) instrument.

Secondary Outcome Measures

Full Information

First Posted
March 7, 2022
Last Updated
September 1, 2023
Sponsor
Rambam Health Care Campus
Collaborators
CogMe Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT05311761
Brief Title
CogMe for the Prevention and Early Detection of Delirium
Acronym
CogMe
Official Title
Evaluation of the CogMe Technology Platform for the Prevention and Early Detection of Delirium Among Older Patients in an Acute Hospital Setting: A Proof of Concept Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rambam Health Care Campus
Collaborators
CogMe Ltd

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed as a prospective interventional study to evaluate the CogMe system for early detection and prevention of delirium. The study will collect physiological and cognitive measurements to evaluate the ability of the CogMe system to predict and detect delirium and to aid the development of future delirium prevention methods.
Detailed Description
Delirium is a syndrome defined as an acute disturbance of both consciousness and cognition that tends to fluctuate over time and is caused by the physiological consequences of a medical condition. It is a common disorder in acute care settings, in internal medicine units, in post-operative patients and the intensive care unit. Delirium is associated with increased mortality, longer hospital stays, long-term cognitive impairment and increased healthcare costs. The pathophysiology of delirium is multifactorial and is not completely understood. The prevalence of delirium increases with age and is very common in elderly hospitalized patients. In certain departments delirium rates can reach over 40%. However, delirium is underdiagnosed in almost two thirds of cases or misdiagnosed as depression or dementia. Furthermore, it has been previously shown that the diagnosis of delirium is often delayed, and that the recognition and documentation of delirium by physicians and nurses is far from optimal. Early diagnosis of delirium may improve clinical outcome, with shortened duration of symptoms, decreased length of admission and reduced long-term complications. Clinical studies have demonstrated that delirium may be prevented in up to one-third of cases by multifactored non-pharmacological interventions, yet they can be costly to implement and require specially trained staff members. In addition, they do not usually consider physiological parameters. Three recent technological advances now provide opportunities for a new delirium prevention approach. First, over the recent years vital signs monitoring with wearable sensors powered by advanced processing algorithms has become technically feasible. This development may provide opportunities for early detection of delirium and for detection of physiological triggers of delirium such as dehydration, infections, and lack of sleep. Second, recent advances in virtual dialogue systems (e.g. Amazon's Alexa or Apple's Siri) provide new and exciting opportunities for automatic patient interaction. Devices with voice or multimodal communication can be used by older patients with little or no experience in modern mobile technology. Lastly, recent progress in digitized data acquisition, computing infrastructure and algorithm development, now allow artificial intelligence and machine learning applications to expand into areas in medicine that were previously thought to be only the province of human experts. The combination of these three data sources can greatly improve current prediction models and allow for earlier and more accurate delirium prediction. An automated system which could aid with delirium detection and alert clinicians to a possible onset of the syndrome can greatly improve treatment and outcomes for patients. The CogMe system utilizes current technology to provide a holistic and scalable approach for delirium prediction, detection and prevention covering both physiological and cognitive aspects. The system uses wearables for physiological vitals monitoring and communicates with patients by a dedicated tablet app - the CogMe Personal Assistant (PA). In this study, the data collected by the wearables and the CogMe PA, in combination with patient data from the EMR, will be analyzed retrospectively using machine learning techniques (CogMe Data Analytics) to evaluate the ability of the CogMe system to predict and detect delirium.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium
Keywords
Elderly, Acute hospitalization, Technology

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single arm single center prospective interventional study.
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CogMe Personal Assistant (PA)
Arm Type
Experimental
Arm Description
The CogMe PA is a dedicated application built by CogMe with the purpose of assessing the cognitive functions of patients and providing them with a short and stimulating interaction. The application runs on a standard tablet. The CogMe PA is designed to be easily understandable and usable also for older adults with little or no experience in mobile applications. The questions in the Q&A session are based on validated cognitive tests shown to be associated with delirium and are built to assess the subjective wellbeing and cognitive function of the patients. The repeated use of the application will allow to detect any changes or anomalies during the hospitalization period.
Intervention Type
Other
Intervention Name(s)
CogMe Personal Assistant (PA)
Intervention Description
Twice a day, in the morning and evening, the electronic tablet with the CogMe PA will be given to the patient by the research assistant. Patients will be asked to respond to a short question and answer (Q&A) session of approximately 5-10 minutes duration. This intervention will continue throughout the hospitalization period, estimated at approximately 5 days.
Primary Outcome Measure Information:
Title
The detection of delirium by the CogMe system
Description
Time between the detection of delirium by the CogMe Data Analytics model and the first diagnosis of delirium based on the Confusion Assessment Method (CAM) instrument.
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female patients aged 65 years of age and older. Patients with an expected length of hospitalization of 4 days or longer. Patients who are conscious and cognitively able to provide written informed consent as suggested by a score of 0 on 4AT screening. Patients who have no diagnosis of delirium prior to enrollment. Exclusion Criteria: Male and female patients younger than 65 years of age. Patients with an expected length of hospitalization of less than 4 days. Patients with uncorrected visual or hearing impairment. Patients with impaired consciousness or cognitive impairment as determined by a score of 1 or more on 4AT screening.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tzvi Dwolatzky, MD MBBCh
Phone
+972502061183
Email
t_dwolatzky@rambam.health.gov.il
First Name & Middle Initial & Last Name or Official Title & Degree
Orit Meshulam
Phone
+972-47772952
Email
o_meshulam@rambam.health.gov.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tzvi Dwolatzky, MD MBBCh
Organizational Affiliation
Rambam Health Care Campus
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rambam Health Care Campus
City
Haifa
State/Province
North
ZIP/Postal Code
3109601
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tzvi Dwolatzky
Phone
502061183
Email
t_dwolatzky@rambam.health.gov.il
First Name & Middle Initial & Last Name & Degree
Orit Meshulam
Phone
972-47772952
Email
o_meshulam@rambam.health.gov.il

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Data will be available to other researchers on request .
Citations:
PubMed Identifier
16540616
Citation
Inouye SK. Delirium in older persons. N Engl J Med. 2006 Mar 16;354(11):1157-65. doi: 10.1056/NEJMra052321. No abstract available. Erratum In: N Engl J Med. 2006 Apr 13;354(15):1655.
Results Reference
result
PubMed Identifier
30076080
Citation
Hshieh TT, Yang T, Gartaganis SL, Yue J, Inouye SK. Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness. Am J Geriatr Psychiatry. 2018 Oct;26(10):1015-1033. doi: 10.1016/j.jagp.2018.06.007. Epub 2018 Jun 26.
Results Reference
result
PubMed Identifier
31015651
Citation
Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018 Oct;2(10):719-731. doi: 10.1038/s41551-018-0305-z. Epub 2018 Oct 10.
Results Reference
result
PubMed Identifier
8831879
Citation
O'Keeffe ST, Lavan JN. Predicting delirium in elderly patients: development and validation of a risk-stratification model. Age Ageing. 1996 Jul;25(4):317-21. doi: 10.1093/ageing/25.4.317.
Results Reference
result
PubMed Identifier
11129764
Citation
Inouye SK, Bogardus ST Jr, Baker DI, Leo-Summers L, Cooney LM Jr. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. J Am Geriatr Soc. 2000 Dec;48(12):1697-706. doi: 10.1111/j.1532-5415.2000.tb03885.x.
Results Reference
result
PubMed Identifier
2240918
Citation
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.
Results Reference
result

Learn more about this trial

CogMe for the Prevention and Early Detection of Delirium

We'll reach out to this number within 24 hrs